Pralatrexate
Details of the Drug
- Generic Name:
- Pralatrexate
- Pronunciation:
- PRAL-a-trek-sate
- Drug Type:
- Antimetabolite
- How the Drug is Given:
Intravenously (IV)
- Names:
- Folotyn®
- Pralatrexate
Indications and Usage
Pralatrexate is FDA approved to treat people who have relapsed or refractory peripheral T-cell lymphoma. It is being studied to treat people who have other forms of lymphoma including diffuse large B-cell lymphoma.
Side effects needing medical attention
Mouth sores; tiredness (fatigue); nausea; myelosuppression; infections.
For information on how to manage the costs of drug therapy, please see Financial Support, or to speak with an Information Specialist, call (800) 955-4572.